ENCANTO (ENgineered CArtilage from Nose for the Treatment of Osteoarthritis) is an international multicenter randomized clinical phase II study on knee-cap osteoarthritis.

This therapy is expected to regenerate the cartilage tissue, sustainably restore joint homeostasis, reduce pain, improve mobility and thereby enable an active life for young and elderly patients.

The study is funded by the European Union within the frame of the Horizon Europe project: HORIZON-HLTH-2023-TOOL-05-01 under grant agreement No.101137315.